Scopolamine: An old drug with new psychiatric applications

Scopolamine is an anticholinergic drug with many uses. For example, it prevents nausea, vomiting, and motion sickness.

However, is re-emerging as an antidepressant, with recent studies showing that scopolamine can rapidly improve mood in . In addition, in a new study published in Biological Psychiatry this month by Dr. Moriel Zelikowsky and colleagues at the University of California, Los Angeles, it may also be a possible treatment for .

Exposure therapy, where the key goal is the elimination of fear through repeated 'safe' exposure to the threat, is commonly employed for the treatment of anxiety disorders. However, its effectiveness is diminished because humans and animals alike tend to be very sensitive to context, causing extinction learning to be dependent on the environment in which it occurs. This makes memories formed during extinction unstable. As a result, extinguished fears commonly return when people put themselves in new situations.

"Current research aimed at treating this problem either employs invasive, untranslatable methods or attempts to strengthen extinction learning rather than prevent relapse," explained senior author Dr. Michael Fanselow.

In an effort to solve this dilemma, Fanselow and his team took a novel . Employing an animal model of exposure therapy, they found they were able to disrupt the rats' contextual processing during extinction using low doses of scopolamine, which blocked the return of fear when the rats were exposed to both the original and a new context.

"This finding provides groundbreaking evidence that changing the nature of extinction learning, rather than its magnitude, can produce profound improvements in the prevention of relapse," added Fanselow.

Scopolamine also slowed the rate of extinction , which was overcome by adding training sessions. Taken together, these findings indicate that scopolamine may serve as a promising pharmacological adjunct to by improving one's resiliency to environmental changes.

"The emerging new uses for scopolamine are quite promising, although further research is needed," commented Dr. John Krystal, Editor of . "These new data are a wonderful example of the capacity of translational neuroscience approaches to identify new uses for old medications."

More information: doi: 10.1016/j.biopsych.2012.08.006

Related Stories

Brain activity predicts response to scopolamine

Jan 31, 2013

(HealthDay)—The neural response in the visual cortex while processing emotional information can predict which patients with major depressive disorder will respond to scopolamine, according to a study published ...

Treating addiction by eliminating drug-associated memories

Apr 23, 2009

Addicts, even those who have been abstinent for long periods of time, are often still vulnerable to their own memories of prior drug use.  For example, exposure to the same environment in which they commonly used drugs - ...

A new generation of rapid-acting antidepressants?

Mar 01, 2010

Conventional antidepressant treatments generally require three to four weeks to become effective, thus the discovery of treatments with a more rapid onset is a major goal of biological psychiatry. The first drug found to ...

Recommended for you

Religious music brings benefit to seniors' mental health

Apr 18, 2014

A new article published online in The Gerontologist reports that among older Christians, listening to religious music is associated with a decrease in anxiety about death and increases in life satisfaction, self-e ...

User comments